Go Back
Neuronetics, Inc. reports $10.5 million Q1 loss
By USInMinutes - May 09, 2023, 01:47 PM ET
Last Updated - Jul 18, 2023, 03:33 PM EDT
The company generated $15.50 million in quarterly revenue
Neuronetics, Inc. [STIM] has reported fiscal Q1 loss of $10.50 million.
On a per-share basis, the DE based company said its diluted earnings are $0.38.
The Surgical & Medical Instruments & Apparatus firm posted revenue of $15.50 million in this period.
Also Read:
- Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
- Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
- Neuronetics Announces Expanded TMS Access through United HealthCare
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News
